Learn more about whether Charles River Laboratories International, Inc. or Thermo Fisher Scientific Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
In the last year, many Thermo Fisher Scientific Inc. insiders sold a substantial stake in the company which may have sparked shareholders' attention. When evaluating insider trans ...
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 ...
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their ...
The race to develop effective Alzheimer's treatments represents a multi-billion dollar opportunity, and Thermo Fisher Scientific is cementing its position as a critical data provider within this space ...
The legendary manager has taken on two co-managers to help him run the mammoth fund. Just don’t use the word “retirement.” ...
Investing.com -- The life sciences and diagnostic tools sector is poised for growth in 2026, with several companies well-positioned to capitalize on improving market conditions. According to Bank of ...
Opinion
Zacks Investment Research on MSNOpinion
3 medical instrument stocks to counter industry woes using GenAI
Over the past year, the application of generative AI (genAI) in the Medical Instruments industry has moved from experimental to operational, transforming diagnostics, patient monitoring and ...
MarketBeat on MSN
Sector Rotation: 2 Smart Money Moves for 2026
Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.
Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that its board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results